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Introduction
Differences in the DNA sequence between humans are responsible 
for much of the variation in sport- and exercise-related traits. For 
example, the heritability (the proportion of phenotypic variation in 
a population which is due to inter-individual genetic variation) may 
be as high as 50% for maximal oxygen uptake (VO2max) (Bouchard 
et al., 1998) and its trainability (Bouchard et al., 1999). However, 
we know comparatively little about the molecular variations 
in the DNA sequence that add up to the often 50% or more 
estimated heritability for major sport- and exercise-related traits 
such as cardiovascular fitness, strength, maximal-intensity exercise 
ability and muscle fibre composition (reviewed in Hagberg et al., 
2011), although the science is progressing. Consequently, an era 
where genetic testing in sport and exercise contexts becomes 
commonplace is approaching, and this raises several ethical 
concerns. This statement summarises an original BASES position 
stand on this topic (Williams et al., 2007). 
Background and evidence
Scientific progress
Sport and exercise genetics (also referred to as athleticogenomics 
or kinesiogenomics) remains in its infancy, with a requirement 
for greater replication of the hundreds of genotype-phenotype 
associations reported to date (Hagberg et al., 2011). Examples 
of promising but still contested associations between genetic 
variants and aspects of exercise performance include an insertion/
deletion (I/D) polymorphism in the ACE gene associated with the 
training-responsiveness of oxygen uptake during exercise, a single 
nucleotide polymorphism (SNP) in the ACTN3 gene associated with 
sprint performance and a SNP in the HIF1A gene associated with 
endurance performance.
Those polymorphisms identified to date account, individually, 
for only a small proportion of the inter-individual variability in 
phenotype. To explain a larger proportion of the variability requires 
either the identification of rare variants of large effect or favourable 
combinations of many common variants. Evidence for rare variants 
of large effect is currently limited to one or two mutations such as 
those in the myostatin and erythropoietin receptor genes. However, 
using 6-10 common variants, elite athletes in certain sports have 
been shown to differ in polygenic profile from non-athletes and 
from elite athletes in other sports (e.g., Ahmetov et al., 2009) and 
such differences will become clearer as larger panels of appropriate 
variants are included. It is estimated that if more than ~15-20 
common variants contribute to sporting ability (most scientists 
suspect it is many more), then more genetic potential exists in the 
human species than is ever likely to manifest itself in one individual 
(Williams & Folland, 2008).
Recently, 21 SNPs were identified that appear to capture the 
heritable component (approximately 50% of total inter-individual 
variability) of the response of VO2max to endurance training 
(Bouchard et al., 2011). While this observation needs replication, it 
shows great promise for increasing the ability to predict individual 
responses to exercise training in advance - something that has been 
desirable but, until now, impossible. One could envisage GPs (and 
indeed health care trusts) using genetic tests to predict changes in 
VO2max, systolic blood pressure or fasting blood glucose of a patient 
in response to an exercise programme. Such information could 
be used to place greater emphasis on exercise for those likely to 
respond and on drugs for those less likely to respond to exercise 
training. Similarly, one could envisage care strategies (exercise 
training and pharmaceuticals) for the maintenance of muscle 
mass and function during ageing being informed by a prediction of 
training responsiveness based on genetic information. Sport and 
exercise scientists should seek to generate sufficient evidence to 
determine whether a “personalised medicine” or “exercise for all” 
approach (or some combination of the two) is the most effective 
strategy to prevent and treat disease.
Ethical concerns
Human genetic research requires ethics committee approval and 
must comply with the World Medical Association’s Declaration of 
Helsinki. Recommendations of bodies such as the Human Genetics 
Commission should also be followed. We conclude that the ethical 
concerns about genetic research itself are relatively small because 
of the scrutiny imposed by ethics committees and other bodies.
One specific aspect of genetic research in the sport and 
exercise sciences that is potentially problematic is the investigation 
of inter-racial differences. Some scientists are fascinated by the 
remarkable success of East African endurance athletes and of 
sprinters of West African descent, and this has stimulated research 
aimed at identifying the reasons for this success. However, using 
molecular genetic methods in these efforts might inadvertently 
help others perpetuate racial stereotypes about race, performance 
and intelligence, and some people reject genetic research where 
ethnic groups are compared for this reason. Yet some ethnic groups 
are underrepresented in clinical trials, despite suffering more from 
some diseases. Thus, there are both advantages and disadvantages 
for investigating genetic differences between ethnic groups.
Looking beyond research per se, towards an era where our 
understanding of the role of genetics in sport and exercise is 
greater than now, there are various applications that raise ethical 
concerns. In sport, for genetic performance tests to be treated 
differently from more traditional physiological tests requires the 
identification of fundamental differences between traditional 
and genetic performance tests. This reflects the “genetics 
exceptionalism” concept, concerning whether genetic testing or 
data are special and thus require bespoke regulation. Genetic and 
traditional performance tests are similar in many ways, but we 
see two important differences. The first is that unexpected, major 
disease associations are more likely to be discovered after a genetic 
test has been conducted than after a traditional performance test. 
Genetic counselling before a genetic test can help to prepare an 
individual for the potential implications of such findings. The second 
difference is that genetic tests (i.e., tests of DNA sequence) can 
be carried out as soon as genomic DNA can be obtained; in sharp 
contrast to a traditional performance test, a genetic performance 
test conducted on an embryo will yield the same information as 
a genetic test performed on an adult. 
Consent cannot be obtained from 
embryos or very young children.
Many forms of sport and exercise 
are effective at improving health, yet 
some activities increase the risk of 
injury, disease or sudden death, and 
there is a genetic component to those 
risks. Thus, it is foreseeable that genetic 
tests will be developed to stratify 
this risk. For example, genetic tests 
could be used to make choices about 
an athletic career by judging injury 
risk, to determine insurance costs or 
coverage for sports participation, to 
help a sports club decide whether 
or not to employ an athlete, or to 
assist the individualisation of care for 
an at-risk or injured athlete. Genetic 
testing may play an important role in 
pre-participation screening and reduce 
the incidence of sudden death in sport. 
Simultaneously, problems might arise 
because of difficulties keeping genetic 
test results confidential, especially those 
of high-profile athletes. A conflict of 
interest could occur between clubs 
and athletes and some healthy athletes 
might erroneously be prevented from 
competing because genetic tests of 
future poor health or injury are unlikely 
to achieve 100% predictive accuracy.
Conclusions and recommendations
The future of sport and exercise science 
will become increasingly focused on 
genetic research and testing as the 
relevant molecular technologies become 
faster, cheaper and more widely available 
(Lander, 2011). Sport and exercise 
scientists need to ensure that they 
keep abreast with genomic science to 
capitalise on recent and anticipated 
findings in an ethically acceptable 
manner. It is recommended that:
• Sport and exercise scientists should 
maintain their awareness of potential 
unwanted consequences of genetic 
information and of the potential 
misuse of genetic data to justify 
discriminatory views or practices. 
Sport and exercise scientists should 
engage knowledgeably in public 
debates to minimise those risks.
• Genetic testing in the sport and 
exercise context (with the possible 
exception of pre-participation risk 
screening) should only be conducted 
on mature individuals who fully 
understand the relevant issues and 
a system of counselling should be 
introduced.
• Pre-participation risk screening 
should not be obligatory and the 
confidentiality of such testing has to 
be ensured.
• Sport and exercise scientists should 
be aware of the risk that a prominent 
“individualised medicine” public 
narrative could undermine the 
more general advice given to large 
population groups regarding the value 
of exercise and other lifestyle factors 
in disease prevention and treatment.
• Genetic testing should be used in 
the fight against doping in sport 
where appropriate, to link biological 
samples to athletes, test claims that 
a genetic mutation was responsible 
for a positive doping test or unusual 
biochemical data, and test for gene 
doping.
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Left: Eero Mantyranta, multiple Olympic medal winner, had a rare 
mutation in his EPOR gene
